These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35311708)

  • 1. Patterns of Mixed Pathologies in Down Syndrome.
    Ichimata S; Yoshida K; Visanji NP; Lang AE; Nishida N; Kovacs GG
    J Alzheimers Dis; 2022; 87(2):595-607. PubMed ID: 35311708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
    Cong C; Zhang W; Qian X; Qiu W; Ma C
    J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of glial tau pathology and LATE-NC in the ageing brain.
    Forrest SL; Wagner S; Kim A; Kovacs GG
    Neurobiol Aging; 2022 Nov; 119():77-88. PubMed ID: 35977443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series.
    Kovacs GG; Milenkovic I; Wöhrer A; Höftberger R; Gelpi E; Haberler C; Hönigschnabl S; Reiner-Concin A; Heinzl H; Jungwirth S; Krampla W; Fischer P; Budka H
    Acta Neuropathol; 2013 Sep; 126(3):365-84. PubMed ID: 23900711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.
    Lemoine L; Ledreux A; Mufson EJ; Perez SE; Simic G; Doran E; Lott I; Carroll S; Bharani K; Thomas S; Gilmore A; Hamlett ED; Nordberg A; Granholm AC
    Mol Neurodegener; 2020 Nov; 15(1):68. PubMed ID: 33222700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome.
    Davidson YS; Robinson A; Prasher VP; Mann DMA
    Acta Neuropathol Commun; 2018 Jul; 6(1):56. PubMed ID: 29973279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic correlates of aging-related tau astrogliopathy: ARTAG is associated with LATE-NC and cerebrovascular pathologies, but not with ADNC.
    Katsumata Y; Wu X; Aung KZ; Gauthreaux K; Mock C; Forrest SL; Kovacs GG; Nelson PT
    Neurobiol Dis; 2024 Feb; 191():106412. PubMed ID: 38244935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
    Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
    Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytic Tau Deposition Is Frequent in Typical and Atypical Alzheimer Disease Presentations.
    Nolan A; De Paula Franca Resende E; Petersen C; Neylan K; Spina S; Huang E; Seeley W; Miller Z; Grinberg LT
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1112-1123. PubMed ID: 31626288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Related Pathology in Corticobasal Degeneration.
    Mimuro M; Iwasaki Y
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDP-43 pathology is associated with increased tau burdens and seeding.
    Tomé SO; Tsaka G; Ronisz A; Ospitalieri S; Gawor K; Gomes LA; Otto M; von Arnim CAF; Van Damme P; Van Den Bosch L; Ghebremedhin E; Laureyssen C; Sleegers K; Vandenberghe R; Rousseau F; Schymkowitz J; Thal DR
    Mol Neurodegener; 2023 Sep; 18(1):71. PubMed ID: 37777806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple system atrophy with amyloid-β-predominant Alzheimer's disease neuropathologic change.
    Kon T; Ichimata S; Di Luca DG; Martinez-Valbuena I; Kim A; Yoshida K; Alruwaita AA; Kleiner G; Strafella AP; Forrest SL; Sato C; Rogaeva E; Fox SH; Lang AE; Kovacs GG
    Brain Commun; 2024; 6(3):fcae141. PubMed ID: 38712319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology of Dementia Disorders.
    Schneider JA
    Continuum (Minneap Minn); 2022 Jun; 28(3):834-851. PubMed ID: 35678405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
    Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
    Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
    Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH
    J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple system aging-related tau astrogliopathy with complex proteinopathy in an oligosymptomatic octogenarian.
    Klotz S; Fischer P; Hinterberger M; Ricken G; Hönigschnabl S; Gelpi E; Kovacs GG
    Neuropathology; 2021 Feb; 41(1):72-83. PubMed ID: 33263220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden.
    McAleese KE; Walker L; Erskine D; Johnson M; Koss D; Thomas AJ; Attems J
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):722-734. PubMed ID: 32896913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.
    Davidson YS; Raby S; Foulds PG; Robinson A; Thompson JC; Sikkink S; Yusuf I; Amin H; DuPlessis D; Troakes C; Al-Sarraj S; Sloan C; Esiri MM; Prasher VP; Allsop D; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
    Acta Neuropathol; 2011 Dec; 122(6):703-13. PubMed ID: 21968532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I716F AβPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-β and α-synucleinopathy with Lewy bodies.
    Sieczkowski E; Milenkovic I; Venkataramani V; Giera R; Ströbel T; Höftberger R; Liberski PP; Auff E; Wirths O; Bayer TA; Kovacs GG
    J Alzheimers Dis; 2015; 44(1):103-14. PubMed ID: 25182745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein astrogliopathies in human neurodegenerative diseases and aging.
    Kovacs GG; Lee VM; Trojanowski JQ
    Brain Pathol; 2017 Sep; 27(5):675-690. PubMed ID: 28805003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.